Skip to content
Loading…
Jamey Millar, Novo Nordisk's Executive Vice President of US Operations, discussed the company's preparations for the upcoming CMS bridge program, which will impact Medicare beneficiaries' access to obesity treatments. Millar highlighted uncertainty about whether patient volume…
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.